Vektor Medical, Inc.
  1. Companies
  2. Vektor Medical, Inc.
  3. News
  4. The feasibility of using vMap in ...

The feasibility of using vMap in patients after COVID-19 Infection presented at THRS 2021.

SHARE
Mar. 31, 2021

COVID-19 is associated with myocardial inflammation which may cause or exacerbate arrhythmias. A study led by Dr. David Krummen was presented at the Taiwan Heart Rhythm Society - Cutting-Edge Care for Heart Rhythm on April 17-18, 2021. The study reports that use of vMap™ computational 12-lead ECG analysis was able to provide arrhythmia insights beyond those available from a standard 12-lead ECG in patients following COVID-19 infection.

Contact supplier

Drop file here or browse